Skip to main content
Filing year 2024

COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA

Carolina, Puerto Rico·EIN 66-0347008·501(c)(14)
Total revenue
$5.2M
Total assets
$88.5M
Total expenses
$5.2M
Reported officers
16
Mission

SAVINGS AND CREDIT UNION OPERATIONS.

Executive compensation

Form 990 · Part VII & Schedule J · 5 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at nonprofits nationwide, across all sectors.

Executive President
Highest Compensated Employee
10th to 25th percentile
$128k
$137k
Gerente IT
Key Employee
25th percentile to median
$64k
$68k
Director De Operaciones
Key Employee
25th percentile to median
$63k
$68k
Comptroller
Controller
10th to 25th percentile
$26k
$28k
Comptroller
Controller
Below 10th percentile
$17k
$19k

Teal figures restate each filed amount in 2026 dollars.

Estimated with national BLS CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 11 unpaid individuals.

Held roughly steady
over 3 years

From $128k in 2021 to $128k in 2024.

$128k
2021
$148k
2023
$128k
2024
In today's dollarsEst.
Down 14% in real terms$159k to $137k

Estimated with national BLS CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Highest Compensated Employee pay held roughly steady from 2021 to 2024, while revenue rose 18%.

$128k in 2021 to $128k in 2024.
  • Key Employee pay rose 39% from 2021 to 2024.
  • Controller pay fell 53% from 2021 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2021 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.
Financial trend

Revenue and expenses over time

COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA reported revenue and expenses across 3 filing years.

RevenueExpenses
$4.4M
$4.2M
2021
$5.3M
$5.4M
2023
$5.2M
$5.2M
2024
Total revenue and total expenses from IRS Form 990 filings.
FAQ

Common questions about COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA

What does the Highest Compensated Employee of COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA earn?

In 2024, the Highest Compensated Employee of COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA received $128,031 in total compensation. This pay is in the bottom quarter for Highest Compensated Employee roles among nonprofits nationwide, across all sectors, above the lowest 10% of comparable filings. Based on IRS Form 990 data.

How does Highest Compensated Employee pay at COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA compare with similar nonprofits?

Compared with the same role at nonprofits nationwide, across all sectors, the 2024 pay of the Highest Compensated Employee at COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA falls between the 10th and 25th percentiles.

What are COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA's revenue and expenses?

In 2024, COOPERATIVA DE AHORRO Y CREDITO INDUSTRIA BIOFARMACEUTICA reported $5.2M in total revenue and $5.2M in total expenses on its IRS Form 990.

Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.